Does bladder preservation lead to retaining bladder function in patients with nonmetastatic bladder/prostate rhabdomyosarcoma?
Bladder preservation strategies in nonmetastatic bladder/prostate rhabdomyosarcoma result in 40% of all patients surviving event-free with normal bladder function at 6 years.
Of patients with nonmetastatic BP RMS on IRS IV 82% survived 6 years. Bladder function was preserved in 55% (36/66) of event-free survivors. Of all patients entered on study 40% (36 of 88) survive event-free with apparently normal functioning bladders. More precise long-term evaluation of bladder and sexual function will require application of better tools such as urodynamic studies and validated patient surveys.
Arndt et al. (Mon,) studied this question.